Phibro Animal Health Corporation
PAHC
$33.26
-$0.20-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.50B | 1.46B | 1.40B | 1.30B | 1.19B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.50B | 1.46B | 1.40B | 1.30B | 1.19B |
| Cost of Revenue | 1.01B | 991.31M | 956.65M | 890.60M | 806.46M |
| Gross Profit | 488.62M | 473.02M | 443.02M | 405.62M | 384.22M |
| SG&A Expenses | 296.12M | 286.60M | 275.19M | 265.16M | 257.57M |
| Depreciation & Amortization | 2.38M | 2.38M | 2.38M | 2.38M | 2.99M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.31B | 1.28B | 1.23B | 1.16B | 1.07B |
| Operating Income | 190.12M | 184.04M | 165.46M | 138.09M | 123.67M |
| Income Before Tax | 128.85M | 126.23M | 94.64M | 67.99M | 50.55M |
| Income Tax Expenses | 33.62M | 34.14M | 26.82M | 19.73M | 18.76M |
| Earnings from Continuing Operations | 95.23 | 92.09 | 67.82 | 48.26 | 31.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 95.23M | 92.09M | 67.82M | 48.26M | 31.79M |
| EBIT | 190.12M | 184.04M | 165.46M | 138.09M | 123.67M |
| EBITDA | 239.28M | 233.36M | 213.47M | 182.27M | 164.63M |
| EPS Basic | 2.35 | 2.27 | 1.67 | 1.19 | 0.78 |
| Normalized Basic EPS | 2.14 | 2.18 | 1.79 | 1.51 | 1.25 |
| EPS Diluted | 2.34 | 2.26 | 1.66 | 1.18 | 0.78 |
| Normalized Diluted EPS | 2.12 | 2.17 | 1.78 | 1.50 | 1.25 |
| Average Basic Shares Outstanding | 162.12M | 162.09M | 162.06M | 162.03M | 162.03M |
| Average Diluted Shares Outstanding | 163.57M | 163.24M | 163.00M | 162.71M | 162.61M |
| Dividend Per Share | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
| Payout Ratio | 20.43% | 21.13% | 28.69% | 40.30% | 61.17% |